Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

YUFLYMA

ADALIMUMAB-AATY

Standard Dose
40MG/0.4ML
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Prescription
Summary

Approval overview YUFLYMA is listed in Drugs@FDA under application 761219 (BLA).

Marketing status: Prescription Active ingredient ADALIMUMAB-AATY Form and strength INJECTABLE;INJECTION - 40MG/0.4ML Sponsor CELLTRION Submission history Latest submission status date: 2025-10-16 00:00:00.

Structured Monograph

Clinical summary

Approval overview YUFLYMA is listed in Drugs@FDA under application 761219 (BLA). Marketing status: Prescription Active ingredient ADALIMUMAB-AATY Form and strength INJECTABLE;INJECTION - 40MG/0.4ML Sponsor CELLTRION Submission history Latest submission status date: 2025-10-16 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription

Interaction Notes

  • No interaction notes stored yet.
YUFLYMA (ADALIMUMAB-AATY) | Drug Monograph | MedicHelpline